This site is intended for healthcare professionals only
LoginRegister
USFDA nod to JnJ Tremfya for Crohns diseaseJnJ sues in latest bid to halt Medicare drug price negotiations
Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitisEli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger PartnerPfizer, Flagship Pioneering partner to create new pipeline of innovative medicines
Novartis opens new radioligand therapy manufacturing facility in CaliforniaSubmit Revise Protocol for TIN-816 : CDSCO panel Tells Novartis
Piramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issuePiramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issue
Compugen wins on PVRIG European patent opposition pursued by GSK, a third partyCompugen wins on PVRIG European patent opposition pursued by GSK, a third party
Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitisPhase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen
Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USANovartis acquires DTx Pharma for USD 500 million plus milestone payments
Sanofis Tetraxim Vaccine Gets CDSCO Panel Nod for Expanded IndicationSanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease
Hetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible TabletHetero Labs Gets CDSCO Panel Nod To Study Antibiotic Tebipenem Pivoxil Dispersible Tablet
Submit the PSUR data: CDSCO Tells Hetero Biopharma on Phase IV CT protocol of Tenecteplase Lyophilized powder for injectionSubmit the PSUR data: CDSCO Tells Hetero Biopharma on Phase IV CT protocol of Tenecteplase...
Andhra Pradesh allotts 531.77 acres of land to Laurus LabsSubmit additional data: CDSCO Tells Laurus Labs to on Carglumic acid dispersible tablets
X